TCF7L2 and pancreatic neoplasm: ChIP assay results underscored an enhanced interaction between the TCF7L2 protein and the Gαi3 promoter region in both pancreatic cancer tissues and different cells, suggesting that this augmented binding may be a pivotal mechanism behind the upregulation of Gαi3 in pancreatic cancer (see Fig. 12).